« Study: Cholesterol drug lowers blood clot risk - Boston Globe | Home | Filtering Out Bad Cholesterol (HealthCentral) »
Abbott, Astra drug combo works in cholesterol study - Forbes
By fthomas | March 29, 2009
ORLANDO, Fla, March 29 (Reuters) - A combination of Abbott Laboratories (nyse: ABT - news - people )’ new TriLipix triglycerides medicine and a low dose of AstraZeneca Plc (nyse: AZN - news - people )’s Crestor cholesterol drug proved better than the …
Topics: High Cholesterol |